| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2421 |
| 1 | DUPILUMAB | 1746 |
| 2 | METHOTREXATE SODIUM | 1470 |
| 3 | PREDNISONE | 1406 |
| 4 | METHOTREXATE | 1314 |
| 5 | ETANERCEPT | 1291 |
| 6 | SECUKINUMAB | 1219 |
| 7 | ERGOCALCIFEROL | 1146 |
| 8 | ACETAMINOPHEN | 1035 |
| 9 | ASPIRIN | 1035 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 169 | 0.0490 |
| 1 | ENFORTUMAB VEDOTIN | 314 | 0.0400 |
| 2 | ERGOCALCIFEROL | 1146 | 0.0385 |
| 3 | CLINDAMYCIN PHOSPHATE | 166 | 0.0301 |
| 4 | PANITUMUMAB | 338 | 0.0210 |
| 5 | GOLIMUMAB | 247 | 0.0196 |
| 6 | DASATINIB | 165 | 0.0178 |
| 7 | SECUKINUMAB | 1219 | 0.0075 |
| 8 | APIXABAN | 471 | 0.0069 |
| 9 | CETUXIMAB | 207 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3105 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2628 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2425 |
| 3 | Kinase Inhibitor [EPC] | 1866 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1746 |
| 5 | Interleukin-23 Antagonist [EPC] | 1471 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 1382 |
| 7 | Benzodiazepine [EPC] | 1352 |
| 8 | Interleukin-17A Antagonist [EPC] | 1306 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1232 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 117 | 0.1701 |
| 1 | Provitamin D2 Compound [EPC] | 1146 | 0.0385 |
| 2 | Interleukin-17A Antagonist [EPC] | 1306 | 0.0350 |
| 3 | Paramagnetic Contrast Agent [EPC] | 96 | 0.0209 |
| 4 | Blood Viscosity Reducer [EPC] | 65 | 0.0150 |
| 5 | Interleukin-23 Antagonist [EPC] | 1471 | 0.0140 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1232 | 0.0125 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 69 | 0.0118 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 536 | 0.0113 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 119 | 0.0070 |